Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash & Current Investments: 2018-2019

Historic Cash & Current Investments for DiaMedica Therapeutics (DMAC) over the last 2 years, with Sep 2019 value amounting to $9.7 million.

  • DiaMedica Therapeutics' Cash & Current Investments rose 149.95% to $9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $51.2 million, marking a year-over-year change of. This contributed to the annual value of $16.8 million for FY2018, which is N/A change from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Cash & Current Investments stood at $9.7 million, which was down 11.15% from $11.0 million recorded in Q2 2019.
  • In the past 5 years, DiaMedica Therapeutics' Cash & Current Investments registered a high of $16.8 million during Q4 2018, and its lowest value of $3.9 million during Q3 2018.
  • Its 2-year average for Cash & Current Investments is $9.7 million, with a median of $9.7 million in 2019.
  • Data for DiaMedica Therapeutics' Cash & Current Investments shows a peak YoY skyrocketed of 149.95% (in 2019) over the last 5 years.
  • DiaMedica Therapeutics' Cash & Current Investments (Quarterly) stood at $16.8 million in 2018, then spiked by 149.95% to $9.7 million in 2019.
  • Its last three reported values are $9.7 million in Q3 2019, $11.0 million for Q2 2019, and $13.7 million during Q1 2019.